Combined Serum DKK3 and Circulating CD133 Cells as Prognostic Biomarkers for Ovarian Cancer Patients

Combined Serum DKK3 and Circulating CD133 Cells as Prognostic Biomarkers for Ovarian Cancer Patients

Xiao-Cui Nie,1 Fang He,1 Chong Lan,1 Ju-Min Niu,1 Pu Xia2 1Department of Gynaecology, Shenyang Women’s and Children’s Hospital, Shenyang, Liaoning, People’s Republic of China; 2Biological Anthropology Institute, Liaoning Medical University, Jinzhou, Liaoning, People&...

Full description

Bibliographic Details
Main Authors: Nie XC, He F, Lan C, Niu JM, Xia P
Format: Article
Language:English
Published: Dove Medical Press 2021-01-01
Series:OncoTargets and Therapy
Subjects:
dkk3
ovarian cancer
cd133
wnt
prognosis.
Online Access:https://www.dovepress.com/combined-serum-dkk3-and-circulating-cd133-cells-as-prognostic-biomarke-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/combined-serum-dkk3-and-circulating-cd133-cells-as-prognostic-biomarke-peer-reviewed-article-OTT

Similar Items